XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating Expenses:        
Research and development $ 8,497 $ 9,098 $ 13,927 $ 15,616
General and administrative 3,320 3,115 6,863 6,010
Total operating expenses 11,817 12,213 20,790 21,626
Loss from operations (11,817) (12,213) (20,790) (21,626)
Other income (expense):        
Grant income 6,925 6,385 10,351 12,289
Other (income) expense, net 172 (42) (443) (237)
Interest expense (6) (7) (16) (16)
Total other income, net 7,091 6,336 9,892 12,036
Loss before income tax (4,726) (5,877) (10,898) (9,590)
Income tax benefit   125    
Net Loss (4,726) (5,752) (10,898) (9,590)
Unrealized (loss) gain on foreign currency translation (1) (3) 3 (2)
Total comprehensive loss $ (4,727) $ (5,755) $ (10,895) $ (9,592)
Net loss per share, basic (in dollars per share) $ (0.16) $ (0.25) $ (0.37) $ (0.43)
Net loss per share, diluted (in dollars per share) $ (0.16) $ (0.25) $ (0.37) $ (0.43)
Weighted-average common shares outstanding, basic (in shares) 29,614,822 22,595,359 29,356,144 22,511,636
Weighted-average common shares outstanding, diluted (in shares) 29,614,822 22,595,359 29,356,144 22,511,636